|
Market Cap (5-Jun) $23,079,360 (1,609th) |
Close (25-Oct) $0.048 |
Volume (25-Oct) 0 |
Shortsold (25-Jun) 3,768 (0.00%) (647th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.019 |
SUD released this announcement to the ASX on 30 September 2021, 15:58. The announcement is not marked as price sensitive, and is 80 page(s) in length and 1.14MB in size.
You can view all announcements from SUD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from SUD | |
|---|---|
| SUDA becomes Arovella Therapeutics | 22 October 2021, 8:20 |
| Chile Ministry of Health Approval Granted for ZolpiMist | 21 October 2021, 10:00 |
| Results of General Meeting | 14 October 2021, 13:51 |
| Annual Report to shareholders | 30 September 2021, 15:58 |
| Notice of Extraordinary General Meeting/Proxy Form | 15 September 2021, 10:14 |
| Investor Presentation | 7 September 2021, 8:54 |
| Dr John Maher Appointed to SUDA iNKT Cell Therapy SAB | 3 September 2021, 9:04 |
You must be logged in to post a reply.
